-
Spatial transcroptomic analyses against non-metastatic and metastatic lymph node from breast cancer patients
Study
JGAS000616
-
Spatial transcriptome analysis for elucidating progression of early lung adenocarcinoma
Study
JGAS000677
-
Vaccine-Expanded Plasmablast-like B Cells Are Associated with Response to Dendritic Cell Therapy in Metastatic Melanoma
Study
EGAS50000001177
-
Genomic Rearrangements in Pediatric Cancer
Dataset
EGAD00001007701
-
WGS dataset for Genomic rearrangements in Pediatric Cancer
Dataset
EGAD00001008272
-
Detection of brain cancer using genome-wide cell-free DNA fragmentomes
Study
EGAS50000000986
-
The dataset for Detection of brain cancer using genome-wide cell-free DNA fragmentomes
Dataset
EGAD50000001445
-
Data access committee for "Detection of brain cancer using genome-wide cell-free DNA fragmentomes"
Dac
EGAC50000000605
-
Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics - WES
Study
EGAS50000000976
-
Tumor gene project
Study
EGAS50000000984
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Study
EGAS50000000228
-
Characterization of UV DNA damage in B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001008128
-
Neoantigen Peptides derived from V(D)J-recombined Immunoglobulins Drive Outgrowth of Cytolytic CD8+ T-cells
Study
EGAS00001008229
-
Single Cell RNA-Sequencing of BCG Naive and Recurrent Non-Muscle Invasive Bladder Cancer Reveals a CD6/ALCAM-Mediated Immune-Suppressive Pathway
Study
phs003742
-
Pancreatic Cancer NGS WGS data
Study
EGAS50000001078
-
Genomic analysis of HGSOC using long read sequencing
Study
EGAS50000001036
-
Oxford Nanopore long-read sequencing data of high-grade serous ovarian cancer
Dataset
EGAD50000001509
-
MD Anderson Cancer Center HGSOC LRS Data Access Comittee
Dac
EGAC50000000597
-
Targeted Sequencing Data for RESOLVE Clinical Trial
Dataset
EGAD50000001711
-
DFCI Gynecological Oncology Data Access Committee
Dac
EGAC50000000712
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Ontario Institute for Cancer Research; Biliary Tract Cancer
Study
EGAS50000000972
-
WGS data from MTB-Guided Targeted Treatments paper
Dataset
EGAD50000001418
-
Whole Exome Sequencing of Human Gastro-esophageal Cancer PDXs
Study
EGAS50000000966
-
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Study
EGAS00001004615
-
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Study
EGAS50000001166
-
Mutational signatures in normal tissues of patients treated with clinical stage G-quadruplex binder CX5461
Study
EGAS50000001145
-
Re-evaluation of human mitochondrial DNA methylation reveals signals consistent with technical artifacts
Study
EGAS50000001186
-
Dataset of Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dataset
EGAD50000001665
-
Mutational signatures in normal tissues of patients treated with clinical stage G-quadruplex binder CX5461
Dataset
EGAD50000001640
-
NSCLC ctDNA multigenic panel
Dataset
EGAD50000000908
-
DAC Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dac
EGAC50000000694
-
The Formation and Propagation of Human Robertsonian Chromosomes
Study
phs003920
-
Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma
Study
phs004009
-
Rituximab-treated lymphoma patients show correlated deficiency in serological and T cell Spike-specific response after SARS-CoV-2 vaccination: insights from the CORSA Study.
Study
EGAS50000001205
-
Genomic landscape of poorly differentiated thyroid carcinoma
Study
EGAS50000001134
-
Bulk RNA sequencing data of high-grade serous ovarian cancer samples (set 7-17)
Dataset
EGAD50000001370
-
Somatic L1 retrotransposition dynamics in high-grade serous ovarian cancer
Study
EGAS50000001198
-
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
Study
EGAS50000001191
-
Dual inhibition of FLT3 and BCL-2 is effective in preclinical models of BCL11B-activated lineage ambiguous leukemia
Study
EGAS50000000978
-
Transcriptomic dataset from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dataset
EGAD50000001664
-
Data Access Committee for Translational analyses from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dac
EGAC50000000697
-
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/ HPV status
Study
EGAS50000001219
-
CNA differences between RNA-based subtypes of PDAC
Study
EGAS50000001218
-
Ultra-sensitive tumor-informed ctDNA monitoring of treatment response in advanced esophagogastric cancer patients
Study
EGAS50000001224
-
Data Access Committee for Triple Negative Breast Cancer dataset
Dac
EGAC00001003584
-
Microarray CDX or EDX from primary tumor and metastasis
Dataset
EGAD00010002711
-
DAC for "Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients."
Dac
EGAC00001003514
-
WGS data for ctDNA monitoring for NSCLC in TRACERx
Study
EGAS50000001187